Position in ABBV
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$15,506,308
+$2,196,790 QoQ
Shares Held
61,621
+0.7% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
1.41%
of 13F equity value
Holder Rank
#724
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026JACOBS & CO/CA holds $94,475,102 across 9 Drug Manufacturers - General names. ABBV ranks #2 (16.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
29,017 | $34,803,863 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
61,621 | $15,506,308 | |
| 3 | AMGN |
Amgen Inc
|
42,343 | $15,333,247 | |
| 4 | MRK |
Merck & Co., Inc.
|
103,952 | $13,357,832 | |
| 5 | JNJ |
Johnson & Johnson
|
48,675 | $12,361,989 | |
| 6 | PFE |
Pfizer Inc
|
82,804 | $1,993,920 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
4,090 | $516,730 | |
| 8 | NVS |
Novartis AG
|
2,520 | $394,934 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,506,308 | 61,621 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $13,309,518 | 61,196 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $13,389,970 | 58,602 | Shares | Sole | 2026-01-05 | |
| 2025-09-30 | $13,915,554 | 60,100 | Shares | Sole | 2025-10-01 | |
| 2025-06-30 | $11,441,431 | 61,639 | Shares | Sole | 2025-07-02 | |
| 2025-03-31 | $12,660,874 | 60,428 | Shares | Sole | 2025-04-03 | |
| 2024-12-31 | $10,771,107 | 60,614 | Shares | Sole | 2025-01-10 | |
| 2024-09-30 | $12,031,666 | 60,926 | Shares | Sole | 2024-10-01 | |
| 2024-06-30 | $10,607,654 | 61,845 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $11,143,791 | 61,196 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $9,752,727 | 62,933 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $9,424,318 | 63,225 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $8,648,049 | 64,188 | Shares | Sole | 2023-07-11 | |
| 2023-03-31 | $11,468,265 | 71,960 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $12,020,066 | 74,377 | Shares | Sole | 2023-01-13 | |
| 2022-09-30 | $9,853,832 | 73,421 | Shares | Sole | 2022-10-11 | |
| 2022-06-30 | $11,379,941 | 74,301 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $12,330,410 | 76,062 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $10,505,550 | 77,589 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $8,090,465 | 75,002 | Shares | Sole | 2021-10-13 | |
| 2021-06-30 | $7,939,880 | 70,489 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $7,842,595 | 72,469 | Shares | Sole | 2021-04-05 | |
| 2020-12-31 | $7,825,057 | 73,029 | Shares | Sole | 2021-01-12 | |
| 2020-09-30 | $6,312,698 | 72,071 | Shares | Sole | 2020-12-03 | |
| 2020-06-30 | $6,368,151 | 64,862 | Shares | Sole | 2020-07-09 | |
| 2020-03-31 | $4,637,075 | 60,862 | Shares | Sole | 2020-04-13 | |
| No filing history on record for this holder in this stock. | ||||||